UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simultaneous sludge minimization, pollutant and nitrogen removal using integrated MBBR configuration for tannery wastewater treatment

Bioresource technology, 2021-12, Vol.341, p.125748-125748, Article 125748

2021

Volltextzugriff (PDF)

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1001-1009

2021

Volltextzugriff (PDF)

Sustainable Development Through Engineering Innovations: Select Proceedings of SDEI 2020

1, 2021

Volltextzugriff (PDF)

Characterization and prediction of stormwater runoff quality in sub-tropical rural catchments

Water resources, 2017-03, Vol.44 (2), p.331-341

2017

Volltextzugriff (PDF)

Implementation analysis of solid waste management in Ludhiana city of Punjab

Environmental challenges (Amsterdam, Netherlands), 2021-01, Vol.2, p.100023, Article 100023

2021

Volltextzugriff (PDF)

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E4203)

Cancer, 2018-02, Vol.124 (4), p.688-697

2018

Volltextzugriff (PDF)

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Journal of clinical oncology, 2018-06, Vol.36 (16), p.1556-1563

2018

Volltextzugriff (PDF)

Advocating integrated water resources management approach for rural human settlements

International Journal of Hydrology, 2018-05, Vol.2 (3)

Singh Cheema, Puneet Pal

2018

Volltextzugriff (PDF)

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl)

2023

Volltextzugriff (PDF)

Patient-Reported Outcomes Among Patients with High-Risk Untreated Follicular Lymphoma (FL) Randomized to Bendamustine/Rituximab (BR) or Bendamustine/Rituximab with Bortezomib (BVR) Therapy: Results from the ECOG-ACRIN E2408 Study

Blood, 2020-11, Vol.136 (Supplement 1), p.45-46

2020

Volltextzugriff (PDF)

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical cancer research, 2020-09, Vol.26 (17), p.4468-4477

2020

Volltextzugriff (PDF)

A 3-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Clinical cancer research, 2020-06, Vol.26 (17), p.4468-4477

2020

Volltextzugriff (PDF)

A 3-Arm Randomized Phase II Trial with Bendamustine/Rituximab Therapy in Untreated High Risk (HR) Follicular Lymphoma (FL): Bortezomib Induction or Novel IMiD® Continuation (BIONIC) Study from the ECOG-ACRIN Cancer Research Group

Blood, 2017-12, Vol.130, p.482-482

2017

Volltextzugriff (PDF)

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

Blood, 2004-03, Vol.103 (5), p.1787-1790

2004

Volltextzugriff (PDF)

Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E4203)

Cancer, 2017-12, Vol.124 (4), p.688-697

2017

Volltextzugriff (PDF)

MULTIVARIATE ANALYSIS OF WASTEWATER QUALITY OF DIFFERENT RURAL HUMAN SETTLEMENTS IN PUNJAB (INDIA)

Environmental engineering and management journal, 2018-02, Vol.17 (2), p.371-380

2018

Volltextzugriff (PDF)

A phase II prospective trial correlating progression-free survival (PFS) with CYP2D6 activity in patients with metastatic breast cancer treated with tamoxifen: ECOG-ACRIN E3108

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.546-546

2016

Volltextzugriff (PDF)

Effect of bortezomib on complete remission (CR) rate when added to bendamustine-rituximab (BR) in previously untreated high-risk (HR) follicular lymphoma (FL): A randomized phase II trial of the ECOG-ACRIN Cancer Research Group (E2408)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.7507-7507

2016

Volltextzugriff (PDF)

Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.9644-9644

2014

Volltextzugriff (PDF)

Panitumumab Monotherapy in Patients with Metastatic Colorectal Cancer and Cetuximab Infusion Reactions: A Series of Four Case Reports

Clinical colorectal cancer, 2009, Vol.8 (1), p.49-54

2009

Volltextzugriff (PDF)

Analysis of Air Quality Index During Lockdown: A Case of Ludhiana District-Punjab

Sustainable Development Through Engineering Innovations, 2021, Vol.113, p.671-681

2021

Volltextzugriff (PDF)

Sketching of EV Network: A Complete Roadmap

Sustainable Development Through Engineering Innovations, 2021, Vol.113, p.431-442

2021

Volltextzugriff (PDF)

A Sustainable Resource Allocation Techniques for Fog Computing

Sustainable Development Through Engineering Innovations, 2021, Vol.113, p.143-151

2021

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(7)
Female
(5)
Oncology
(5)
Male
(4)
Middle Aged
(4)
Sustainability
(4)
Sustainable Development
(4)
Aged
(3)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Black Cotton Soil
(3)
Prognosis
(3)
Treatment Outcome
(3)
Unconfined Compressive Strength
(3)
Bacteria
(2)
Biological And Medical Sciences
(2)
Biotechnology & Applied Microbiology
(2)
Colorectal Neoplasms - Drug Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simultaneous sludge minimization, pollutant and nitrogen removal using integrated MBBR configuration for tannery wastewater treatment

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

Sustainable Development Through Engineering Innovations: Select Proceedings of SDEI 2020

Characterization and prediction of stormwater runoff quality in sub-tropical rural catchments

Implementation analysis of solid waste management in Ludhiana city of Punjab

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E4203)

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Advocating integrated water resources management approach for rural human settlements

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers

Patient-Reported Outcomes Among Patients with High-Risk Untreated Follicular Lymphoma (FL) Randomized to Bendamustine/Rituximab (BR) or Bendamustine/Rituximab with Bortezomib (BVR) Therapy: Results from the ECOG-ACRIN E2408 Study

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

A 3-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

A 3-Arm Randomized Phase II Trial with Bendamustine/Rituximab Therapy in Untreated High Risk (HR) Follicular Lymphoma (FL): Bortezomib Induction or Novel IMiD® Continuation (BIONIC) Study from the ECOG-ACRIN Cancer Research Group

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E4203)

MULTIVARIATE ANALYSIS OF WASTEWATER QUALITY OF DIFFERENT RURAL HUMAN SETTLEMENTS IN PUNJAB (INDIA)

A phase II prospective trial correlating progression-free survival (PFS) with CYP2D6 activity in patients with metastatic breast cancer treated with tamoxifen: ECOG-ACRIN E3108

Effect of bortezomib on complete remission (CR) rate when added to bendamustine-rituximab (BR) in previously untreated high-risk (HR) follicular lymphoma (FL): A randomized phase II trial of the ECOG-ACRIN Cancer Research Group (E2408)

Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers

Panitumumab Monotherapy in Patients with Metastatic Colorectal Cancer and Cetuximab Infusion Reactions: A Series of Four Case Reports

Analysis of Air Quality Index During Lockdown: A Case of Ludhiana District-Punjab

Sketching of EV Network: A Complete Roadmap

A Sustainable Resource Allocation Techniques for Fog Computing

Suchergebnisse filtern